Related Experiment Video

Updated: Aug 15, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Clinical efficacy of ezetimibe and combined use with statins]

J M Pascual Izuel1, E Rodilla Sala, C Sánchez Juan

  • 1Sevicio de Medicina Interna, Hospital de Sagunto, Valencia. pascual_jma@gva.es

Revista Clinica Espanola
|October 22, 2005
PubMed

Insights

Statins are widely used for cardiovascular patients, but achieving LDL-C goals is challenging. Combining statins with ezetimibe, an intestinal cholesterol absorption inhibitor, enhances LDL-C reduction for high-risk individuals.

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Extensive use of statins in patients with prior cardiovascular events.
  • Current therapeutic targets for low-density lipoprotein cholesterol (LDL-C) are difficult to achieve in clinical practice, particularly for high-risk populations.

Purpose:

  • To evaluate the efficacy of combined ezetimibe and statin therapy in reducing LDL-C levels.
  • To determine if this combination therapy helps high-risk patients achieve therapeutic LDL-C goals more frequently.

Summary:

  • Ezetimibe, a novel inhibitor of intestinal cholesterol absorption, significantly potentiates the LDL-C-lowering effects of statins.
  • Combined ezetimibe-statin therapy offers a promising strategy for achieving greater LDL-C reductions.

Impact:

  • Facilitates achievement of ambitious LDL-C therapeutic objectives in high-risk cardiovascular patients.
  • Enhances clinical management of hyperlipidemia and cardiovascular risk reduction.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...